UPDATE: Stifel Reiterates On HealthSouth As Second Quarter Easily Exceeds Projection

By: via Benzinga
In a report published Tuesday, Stifel analyst Robert Mains reiterated a Buy rating on HealthSouth (NYSE: HLS), and raised the price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.